A Breathtaking Case of Chemotherapy-Induced Pneumonitis.

Authors

Anthony V. Cook, Henry Ford HealthFollow
David I. LeRoy, Henry Ford HealthFollow
Cassie T. Konja, Henry Ford HealthFollow

Recommended Citation

Cook AV, LeRoy DI, and Konja CT. A Breathtaking Case of Chemotherapy-Induced Pneumonitis. Cureus 2025; 17(2):e78791.

Document Type

Article

Publication Date

2-1-2025

Publication Title

Cureus

Abstract

Medication-induced pulmonary toxicity is a rare adverse event that may occur with many chemotherapeutic agents, including etoposide. This agent has been found to cause various toxicities, including anaphylaxis, angioedema, hypotension, and pneumonitis. Etoposide is used in chemotherapy regimens for multiple cancers, including germ-cell tumors. Proper diagnosis of chemotherapy-induced pulmonary toxicity is imperative and should be considered in patients who develop acute respiratory failure during or after chemotherapy. Here, we discuss an unexpected case of etoposide-induced pneumonitis after a short course of IV etoposide in a patient with metastatic seminoma.

PubMed ID

40078233

Volume

17

Issue

2

First Page

78791

Last Page

78791